Amgen first-quarter profit, revenue rise
April 23 (Reuters) - Amgen Inc on Tuesday reported higher first-quarter profit on increased sales of its drug Enbrel for rheumatoid arthritis and newer medicines to help prevent bone fractures.
The world's largest biotechnology company posted a net profit of $1.43 billion, or $1.88 per share, compared with a profit of $1.18 billion, or $1.48 per share, a year ago.
Excluding one time items, Amgen had adjusted earnings of $1.96. Analysts on average expected $1.84 per share, according to Thomson Reuters I/B/E/S.
- Exclusive: Angry with Washington, 1 in 4 Americans open to secession
- U.S. immigration protesters drop U.S. border blockade plan
- Secret Service investigates after man jumps White House fence, reaches doors
- About 60,000 Syrian Kurds flee to Turkey from Islamic State advance |
- Kentucky firefighter dies after ice bucket challenge accident